Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197898 · ClinicalTrials.gov registry record · Phase 4
Wound Edge Changes Following Treatment With Santyl
A Phase 4 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01197898 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 10 participants.
The verdict
NCT01197898, a Phase 4 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.
Interventions
- OTHER Placebo Comparator
- BIOLOGICAL Collagenase Santyl Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197898
The ClinicalTrials.gov registry entry for NCT01197898 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT01197898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197898 about?
NCT01197898 is a clinical study titled "Wound Edge Changes Following Treatment With Santyl". The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.
What is the current status of trial NCT01197898?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2010-12. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01197898?
The interventions under investigation include: Placebo Comparator (OTHER), Collagenase Santyl Ointment (BIOLOGICAL).
Who is sponsoring clinical trial NCT01197898?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.